GRIN2A mutation and early‐onset epileptic encephalopathy: personalized therapy with memantine-Reference-Cited by-同舟云学术

GRIN2A mutation and early‐onset epileptic encephalopathy: personalized therapy with memantine

Published:2014-03 Issue:3 Volume:1 Page:190-198
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Pierson Tyler Mark¹²³,Yuan Hongjie⁴,Marsh Eric D.⁵,Fuentes‐Fajardo Karin¹,Adams David R.¹⁶,Markello Thomas¹⁷,Golas Gretchen¹⁷,Simeonov Dimitre R.¹,Holloman Conisha¹⁷,Tankovic Anel⁴,Karamchandani Manish M.⁴,Schreiber John M.⁸,Mullikin James C.⁹,Tifft Cynthia J.¹⁵,Toro Camilo¹⁵,Boerkoel Cornelius F.¹⁵,Traynelis Stephen F.⁴,Gahl William A.¹⁵

Affiliation:

1. NIH Undiagnosed Diseases Program NIH Office of Rare Diseases Research and NHGRI Bethesda Maryland

2. Neurogenetics Branch NINDS, NIH Bethesda Maryland

3. Department of Pediatrics and Neurology, and the Regenerative Medicine Institute Cedars‐Sinai Medical Center Los Angeles California

4. Department of Pharmacology Emory University School of Medicine Atlanta Georgia

5. Division of Neurology Children's Hospital of Philadelphia and Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania

6. Medical Genetics Branch NHGRI, NIH Bethesda Maryland

7. Office of the Clinical Director NHGRI, NIH Bethesda Maryland

8. EEG Section NINDS, NIH Bethesda Maryland

9. NIH Intramural Sequencing Center NHGRI, NIH Bethesda Maryland

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.39

Reference29 articles.

1. Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region